# Omega Tots Long Term Follow-up

> **NCT05191823** · NA · ENROLLING_BY_INVITATION · sponsor: **Sarah Keim** · enrollment: 377 (estimated)

## Conditions studied

- Preterm Birth
- Child Development

## Interventions

- **DRUG:** Docosahexaenoic Acid + Arachidonic Acid (DHA+AA)
- **DIETARY_SUPPLEMENT:** Placebo

## Key facts

- **NCT ID:** NCT05191823
- **Lead sponsor:** Sarah Keim
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** ENROLLING_BY_INVITATION
- **Start date:** 2021-12-01
- **Primary completion:** 2024-06-25
- **Final completion:** 2026-06-30
- **Target enrollment:** 377 (ESTIMATED)
- **Last updated:** 2025-05-11

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05191823

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05191823, "Omega Tots Long Term Follow-up". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT05191823. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*